What is the upside for Illumina's stock?
Their forecasts range from $340.00 to $570.00. On average, they expect Illumina's stock price to reach $441.17 in the next twelve months. This suggests a possible upside of 16.0% from the stock's current price. View analysts' price targets for Illumina or view top-rated stocks among Wall Street analysts.
What is the target price for Illumina?
Their forecasts range from $340.00 to $570.00. On average, they expect Illumina's stock price to reach $441.17 in the next twelve months. This suggests a possible upside of 16.0% from the stock's current price. View analysts' price targets for Illumina or view top-rated stocks among Wall Street analysts. Who are Illumina's key executives?
What is Illumina's (ilmn) stock price potential in the next year?
Their forecasts range from $340.00 to $570.00. On average, they expect Illumina's stock price to reach $441.17 in the next twelve months. This suggests a possible upside of 16.0% from the stock's current price.
What is Illumina's 52-week low stock price?
The Illumina 52-week low stock price is 318.07, which is 10.8% below the current share price. The average Illumina stock price for the last 52 weeks is 421.17.
See more
Does Illumina pay a dividend?
ILMN Illumina, Inc. ILMN does not currently pay a dividend.
How much does it cost to buy Illumina stock?
Illumina Inc (ILMN) is a leading diagnostics & research business based in the US. It opened the day at $180.67 after a previous close of $177.23. During the day the price has varied from a low of $177.62 to a high of $190.41....Illumina shares at a glance.Open$180.67Volume more info button1,810,6717 more rows
Is Illumina undervalued?
Illumina retains a regular Real Value of $250.12 per share. The prevalent price of the firm is $189.21. At this time, the firm appears to be undervalued....Diagnostics & Research.LowTarget PriceHigh340.00440.36570.00
Who owns Illumina stock?
Top 10 Owners of Illumina IncStockholderStakeShares ownedBlackRock Fund Advisors4.81%7,553,432SSgA Funds Management, Inc.4.07%6,395,221Wellington Management Co. LLP2.38%3,740,675Loomis, Sayles & Co. LP2.25%3,540,7576 more rows
Is Illumina a buy or sell or hold?
Illumina has received a consensus rating of Hold. The company's average rating score is 2.22, and is based on 3 buy ratings, 5 hold ratings, and 1 sell rating.
Why is Illumina stock falling?
Shares of Illumina were falling sharply Friday after the gene-sequencing supplier said that Sam Samad would be departing as its chief financial officer. Samad will leave Illumina (ticker: ILMN) on July 8, after serving as CFO for more than five years, the company said in a news release.
Is Illumina stock a good investment?
Illumina is a good long-term investment since its projects and research will take time to realize returns when its products and patents make their way into the market. Speculators should avoid the stock as it tends to exhibit short-term fluctuation.
Will CRSP stock go up?
Stock Price Forecast The 22 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 108.50, with a high estimate of 220.00 and a low estimate of 46.00. The median estimate represents a +29.55% increase from the last price of 83.75.
Is Ilmn a good buy?
ILMN has been gaining from strategic partnerships in the oncology space. The company ended the fourth quarter of 2021 with better-than-expected results. The robust performance in the reproductive health market buoys optimism. The growing uptake of the company's VeriSeq v2 technology is another advantage.
Should Illumina be allowed to acquire Grail?
FTC lawyers argued on Wednesday that Illumina should fully divest itself of Grail. That would still allow Illumina to retain the 12% stake in Grail it had prior to the merger. Illumina said that it has no reason to put the sequencing needs of Grail ahead of its competitors.
Will Illumina buy Grail?
Despite facing backlash from global powers, Illumina completed its acquisition of Grail in August 2021. The U.S. Federal Trade Commission began suing Illumina to stop the deal, which is still an ongoing ordeal within the courts.
How do I invest in Illumina?
How to buy Illumina Stocks & Shares to Invest in ILMN Steps of buying Illumina sharesStep 1: find a good online broker. ... Step 2: open your brokerage account. ... Step 3: deposit money to your account. ... Step 4: buy the Illumina share. ... Step 5: review your Illumina position regularly.
Should I buy or sell Illumina stock right now?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Illumina in the last year. There are currently 6 hold ratings and 3 buy ra...
What is Illumina's stock price forecast for 2022?
9 equities research analysts have issued 1-year price targets for Illumina's shares. Their forecasts range from $325.00 to $520.00. On average, the...
How has Illumina's stock performed in 2022?
Illumina's stock was trading at $380.44 on January 1st, 2022. Since then, ILMN stock has decreased by 46.3% and is now trading at $204.19. View th...
Are investors shorting Illumina?
Illumina saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 2,470,000 shares, an increase of 2...
When is Illumina's next earnings date?
Illumina is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Illumina .
How were Illumina's earnings last quarter?
Illumina, Inc. (NASDAQ:ILMN) announced its quarterly earnings results on Thursday, May, 5th. The life sciences company reported $1.07 earnings per...
What guidance has Illumina issued on next quarter's earnings?
Illumina issued an update on its FY 2022 earnings guidance on Monday, May, 23rd. The company provided EPS guidance of $4.00-$4.20 for the period, c...
Who are Illumina's key executives?
Illumina's management team includes the following people: Mr. Francis A. deSouza , CEO & Director (Age 51) ( LinkedIn Profile ) Mr. Sam A. Samad...
What is Francis deSouza's approval rating as Illumina's CEO?
496 employees have rated Illumina CEO Francis deSouza on Glassdoor.com . Francis deSouza has an approval rating of 92% among Illumina's employees....
About Illumina
Headlines
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.
Illumina (NASDAQ:ILMN) Frequently Asked Questions
Illumina vs. Qiagen: Which Diagnostics & Research Stock is a Better Buy?
Nasdaq Global Select
10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Illumina in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Illumina stock.
Environmental, Social, and Governance Rating
The company develops, manufactures, and markets next-generation life-science tools and integrated systems to analyze genetic variations and biological functions.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
What is Illumina Inc?
The company develops, manufactures, and markets next-generation life-science tools and integrated systems to analyze genetic variations and biological functions.
What is Illumina valuation?
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
How to calculate restricted stock?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and ...
How long are futures trading delayed?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
Barron's Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And More
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
Expert Ratings For Illumina
This weekend's Barron's cover story says there will be a dramatic increase in betting on this year's Super Bowl, a trend that's likely to continue for years to come.
